All Articles

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

A lost Kazakh oil license reveals more than a regulatory slip-up; it exposes a bitter shareholder war and the high cost of corporate negligence.

After 75 years, the Velan family has sold its controlling stake in the iconic valve maker. A deep dive into the C$204M deal and what it means for the future.

Tri Delta’s 27-year, $185M partnership with St. Jude is more than charity. It's a masterclass in grassroots economic power fueling life-saving innovation.

A new wave of advanced cancer drugs is set to upend the market. As the EGFR inhibitor space surges towards $16B, we analyze the strategies behind the disruption.

Fulton Bank's latest CSR report details hundreds of millions in community investment. Is this just philanthropy, or a calculated strategy for lasting resilience?

As AI's hunger for processing power outstrips supply, a new class of specialized cloud providers is emerging to challenge the giants. But can they deliver?

Beyond the balance sheet, a major Icelandic bank's latest bond issuance reveals a sophisticated strategy for navigating global markets and regulatory demands.

Beyond the perfect steak, a new model for business success emerges, blending operational mastery with the strategic art of 'edvertising.' A deep dive.

As biopharma navigates a maze of privacy laws and AI, a new platform aims to centralize patient consent, turning a compliance nightmare into a bridge for trust.

Calgary's Douglas Vermeeren faces new fraud charges despite a 10-year ban. His case reveals a high-stakes battle between regulators and persistent predators.

As AI-powered cyberattacks escalate, Lumos has launched its 'Identity Agent Force,' an autonomous team of AI agents designed to defend the enterprise.

Immuta's expanded Databricks partnership introduces a new security paradigm for autonomous AI, promising to turn a critical risk into a commercial advantage.

With the appointment of 'serial scaler' Jose Costa, RealManage and its PE backer signal an aggressive new era for the HOA management industry.

A defense tech investor's bet on a Databricks partner reveals a crucial truth: the AI revolution will be built not by algorithms alone, but by modernizing data.

Ascensus's investment in Nonprofitly is more than a fintech deal; it's a strategic move to scale Child Savings Accounts and redefine the future of education.

As AI drug discovery faces a crucial test, Terray Therapeutics hires a proven dealmaker. Can Lisa Decker translate digital promise into clinical reality?

As Netflix preps its Q2 2026 report, investors look past subscriber numbers to the real story: the success of its ad-supported tiers and gaming bets.

A record $10M gift establishes a new research chair, honoring a titan of Canadian finance and positioning Montreal to solve the critical organ shortage.

Anchorage Digital's custody of tokenized CETES marks a milestone, creating a federally regulated blueprint for bringing real-world sovereign debt onto the blockchain.